StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stagezero begins COVID-19 testing for travel to China $$$$$$

<< Previous

Bullboard Posts

Next >>

Comment by frewil11on Dec 09, 2020 1:20pm

101 Views

Post# 32068623

RE:RE:RE:RE:RE:Stagezero begins COVID-19 testing for travel to China $$$$$$

You would think that it would be the same as once you go through the checkpoints [ scanners and sensor devises ] then you enter the security zone [ boarding gates and what not ] it should apply to the COVID testing and of course if you leave this zone you have to get tested again , but thats where the test kits come into play.

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload